CoChat

A new biological enhancement therapy for anterior cruciate ligament reconstruction: the preclinical proof of anterior cruciate ligament reconstruction with tendon graft reseeded with autologous anterior cruciate ligament-derived cells

Open access

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index; 18 of the 68 sources its claims cite were checked for support.

Abstract

BACKGROUND: The current standard of care to treat a ruptured anterior cruciate ligament (ACL) is ACL reconstruction (ACLR), which involves replacing the torn ligament with a tendon graft. The implanted tendon graft undergoes a graft-maturation process known as ligamentization. However, the synthesis of type III collagen, which is typically found in weaker scar tissue, continues at higher concentrations, and the heterogeneous composition of collagen fibers of varying diameters of native ACL is never restored. Culture-expanded ACL-derived cells reseeded to tendon graft have shown the potential for enhanced ligamentization. We performed in vitro and in vivo studies of the outcomes of ACLR with decellularized tendon grafts reseeded with ACL-derived cells combined with acellularized cruciate ligament matrix (ACLM) powder as a biological scaffold. We hypothesized that this tissue-engineered construct would enhance the graft maturation process and mechanical properties of the graft following ACLR. METHODS: ACL-derived cells were harvested and isolated from remnants of ruptured ACLs within 4 weeks of injury in patients who had undergone ACLR. An ACLM was prepared from human ACL and posterior cruciate ligament tissues. Forty-five Sprague Dawley rats were randomly divided into 3 groups: a standard allograft group, an ACLM powder-only injection group, and an ACL-derived cells and ACLM powder co-injection group (e.g., target group). ACL-derived cells were mixed with ACLM powder and then injected into the decellularized tendon graft before ACLR. RESULTS: In vitro experiments found that combining ACLM powder and ACL-derived cells improved survival and integration of reseeded cells in the tendon extracellular matrix, resulting in the successful transplantation of ACL-derived cells. Animal ACLR experiments confirmed histologically improved structural maturation in cellularity, metaplasia, and restoration of collagen crimping in the graft reseeded with ACL-derived cells and ACLM powder. Enhanced gene expression of type I collagen resulted in superior mechanical properties of the tendon graft compared with the control groups. CONCLUSION: Implantation of a tendon graft reseeded with culture-expanded ACL-derived cells, and ACLM powder enhanced the tendon graft's maturation process and mechanical properties. We provide in vitro and in vivo proof-of-concept evidence supporting the efficacy of reseeding a tendon graft with ACL-derived cells combined with ACLM powder as a biological scaffold for ACL reconstruction.

Overview

CoChat Summary

TL;DR

This preclinical study tested whether reseeding decellularized tendon grafts with autologous ACL-derived cells plus acellularized cruciate ligament matrix (ACLM) powder could improve ACL reconstruction healing. In vitro and rat in vivo results showed better cell survival/integration, higher type I collagen expression, improved graft maturation, and stronger mechanical properties than controls.

Key findings

  • In vitro, adding ACLM powder improved seeding efficiency; the 30 mg/mL ACLM group had significantly higher cell seeding efficiency than the 10 and 60 mg/mL groups (p < 0.001).
  • In vitro, the target group showed more surviving/integrated cells on day 14 than ACL-derived cells alone (p < 0.001), stronger type I collagen staining, and higher type I collagen mRNA (p < 0.01); type III collagen, tenascin C, and smooth muscle A were not significantly different.
  • In rat ACL reconstruction, the target group had less metaplasia at 4 weeks and more mature-looking cells and better collagen crimp restoration at 8 weeks than controls.
  • Mechanical outcomes improved: ultimate failure load was 20.400 ± 0.949 N in the target group vs 13.125 ± 0.431 N in standard allografts, a 55.4% increase (p < 0.001); stiffness was 9.508 ± 1.020 N/mm vs 3.410 ± 0.942 N, a 178.8% increase (p = 0.005).
  • Micro-CT showed increased new bone formation at the femoral tunnel (95.3% increase, p = 0.0219) and tibial tunnel (48.4% increase, p = 0.0113), with a higher tibial tunnel BV/TV ratio (27.6% increase, p = 0.0152).

Methods

  • The study combined in vitro tendon-graft reseeding experiments and an in vivo rat ACL reconstruction model. Human ACL-derived cells came from 15 patients; ACLM powder came from 2 osteoarthritic donors.
  • For rats, 45 male Sprague Dawley rats were randomized into 3 groups: standard allograft, ACLM powder-only injection, and ACL-derived cells + ACLM powder co-injection (target).
  • Analyses included histology, immunohistochemistry/immunofluorescence, RT-qPCR, biosensor-based FRET imaging for talin tension and FAK activity, mechanical testing at 8 weeks, and micro-CT at 8 weeks.

Limitations

  • The paper states that homogeneous injection of cells into the whole tendon graft was not possible, so results may not represent the entire graft.
  • The ACL donors were mainly young males, so findings may not generalize to all patient populations.
  • Only early time points (within 8 weeks) were analyzed, so long-term effects are unknown.
  • The sample size at each time point was small and the study period was relatively short for mechanical assessment.
  • The authors note that Sprague Dawley rat biomechanics differ from humans and that response to human-originated cells may vary between species; therefore, the findings cannot be generalized to humans.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s13287-025-04760-1

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Preparation and characterization of acellularized cruciate ligament matrix. A ACLM powder was produced from human ACL and PCL. B ACLM powder was lysed, and type I collagen protein was analyzed by immunoblotting (Full-length blots are presented in Supplementary material 2). C The seeding efficiency of ACL-derived cells was analyzed within the tendon graft on day 1, depending on the concentration of ACLM. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ns: not significant. Statistical analysis of the data was performed using a 1-way analysis of variance. Data are shown as mean ± standard error of the mean
Fig. 1 Preparation and characterization of acellularized cruciate ligament matrix. A ACLM powder was produced from human ACL and PCL. B ACLM powder was lysed, and type I collagen protein was analyzed by immunoblotting (Full-length blots are presented in Supplementary material 2). C The seeding efficiency of ACL-derived cells was analyzed within the tendon graft on day 1, depending on the concentration of ACLM. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ns: not significant. Statistical analysis of the data was performed using a 1-way analysis of variance. Data are shown as mean ± standard error of the meanCC BY-NC-ND · PubMed Central
Fig. 2 Histology, matrix protein contents, and gene expression in vitro. A Integration of ACL-derived cells was analyzed using H&E staining. Magnification ×200, scale bar: 200 μm. The black arrows indicate the newly formed collagen matrix. B The number of ACL-derived cells was counted on 5 consecutive slides on day 14 (n = 5). C Types I and III collagen expressed by ACL-derived cells in tendon grafts were stained with Picrosirius red on day 14. Magnification ×200, scale bar: 200 μm. D Co-immunofluorescence staining for Ki-67 and type I collagen was conducted on day 14. Magnification ×1000, scale bar: 20 μm. E Ki-67 or type I collagen-positive cells were counted on 5 consecutive slides on day 14 (n = 5). F The mRNA expression levels of collagens (type I and III collagen) and ligament-related markers (tenescin C and smooth muscle A) were analyzed by RT-qPCR (n = 3). *, p < 0.05; **, p < 0.01; ***, p < 0.001; ns: not significant. Statistical analysis of the data was performed using a 2-tailed paired t-test. Data are shown as mean ± SEM
Fig. 2 Histology, matrix protein contents, and gene expression in vitro. A Integration of ACL-derived cells was analyzed using H&E staining. Magnification ×200, scale bar: 200 μm. The black arrows indicate the newly formed collagen matrix. B The number of ACL-derived cells was counted on 5 consecutive slides on day 14 (n = 5). C Types I and III collagen expressed by ACL-derived cells in tendon grafts were stained with Picrosirius red on day 14. Magnification ×200, scale bar: 200 μm. D Co-immunofluorescence staining for Ki-67 and type I collagen was conducted on day 14. Magnification ×1000, scale bar: 20 μm. E Ki-67 or type I collagen-positive cells were counted on 5 consecutive slides on day 14 (n = 5). F The mRNA expression levels of collagens (type I and III collagen) and ligament-related markers (tenescin C and smooth muscle A) were analyzed by RT-qPCR (n = 3). *, p < 0.05; **, p < 0.01; ***, p < 0.001; ns: not significant. Statistical analysis of the data was performed using a 2-tailed paired t-test. Data are shown as mean ± SEMCC BY-NC-ND · PubMed Central
Fig. 3 YAP protein expression by ACL-derived cells in tendon graft: in vitro. A Co-immunofluorescence staining for Ki-67 and YAP was performed on day 14. Magnification ×1000 and ×2000, scale bar: 20 μm. The white arrows indicate the translocated YAP1 proteins. B YAP-positive cells were counted on 4 consecutive slides on day 14 (n = 4). *, p < 0.05; **, p < 0.01; ***, p < 0.001; ns: not significant. Statistical analysis of the data was performed using a 2-tailed paired t-test. Data are shown as mean ± standard error of the mean
Fig. 3 YAP protein expression by ACL-derived cells in tendon graft: in vitro. A Co-immunofluorescence staining for Ki-67 and YAP was performed on day 14. Magnification ×1000 and ×2000, scale bar: 20 μm. The white arrows indicate the translocated YAP1 proteins. B YAP-positive cells were counted on 4 consecutive slides on day 14 (n = 4). *, p < 0.05; **, p < 0.01; ***, p < 0.001; ns: not significant. Statistical analysis of the data was performed using a 2-tailed paired t-test. Data are shown as mean ± standard error of the meanCC BY-NC-ND · PubMed Central
Fig. 4 Mechanotransduction-related marker expression by ACL-derived cells in tendon graft: in vitro. A FRET, tagRFP, DAPI, DIC, and tagRFP/FRET ratio images of ACL-derived cells expressing TalinTS in tendon graft were detected on day 14. Magnification ×40, scale bar: 100 μm. B tagRFP/FRET ratio was analyzed on day 14 (n = 11). C FRET, ECFP, DAPI, DIC, and ECFP/FRET ratio images of ACL-derived cells expressing Lyn FAK in tendon graft were detected on day 14. Magnification ×40, scale bar: 100 μm. D ECFP/FRET ratio was analyzed on day 14 (ACL, n = 6; ACL + ACLM, n = 13). *, p < 0.05; **, p < 0.01; ***, p < 0.001; ns: not significant. Statistical analysis of the data was performed using a 2-tailed paired t-test. Data are shown as mean ± standard error of the mean
Fig. 4 Mechanotransduction-related marker expression by ACL-derived cells in tendon graft: in vitro. A FRET, tagRFP, DAPI, DIC, and tagRFP/FRET ratio images of ACL-derived cells expressing TalinTS in tendon graft were detected on day 14. Magnification ×40, scale bar: 100 μm. B tagRFP/FRET ratio was analyzed on day 14 (n = 11). C FRET, ECFP, DAPI, DIC, and ECFP/FRET ratio images of ACL-derived cells expressing Lyn FAK in tendon graft were detected on day 14. Magnification ×40, scale bar: 100 μm. D ECFP/FRET ratio was analyzed on day 14 (ACL, n = 6; ACL + ACLM, n = 13). *, p < 0.05; **, p < 0.01; ***, p < 0.001; ns: not significant. Statistical analysis of the data was performed using a 2-tailed paired t-test. Data are shown as mean ± standard error of the meanCC BY-NC-ND · PubMed Central
Fig. 5 Histological features in a rat model after ACL reconstruction. A Design of in vivo experiments with a rat model after ACL reconstruction. B Each tendon graft was analyzed using H&E staining. The grade of cellularity and the metaplasia were evaluated on an enlarged image. Black arrows indicate round, white arrows indicate oblong, red arrows indicate spindle, and yellow arrows indicate linear shapes. Magnification ×100 and ×200, scale bar: 200 μm. C The cellularity and metaplasia grade was calculated on 4 consecutive slides 4 and 8 weeks after ACLR. D Picrosirius red staining of rat tendon graft was performed to observe the crimp pattern (black arrow) with a polarized light microscope. Magnification ×200, scale bar: 200 μm. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ns: not significant. Statistical analysis of the data was performed using a 2-way analysis of variance. Data are shown as mean ± standard error of the mean
Fig. 5 Histological features in a rat model after ACL reconstruction. A Design of in vivo experiments with a rat model after ACL reconstruction. B Each tendon graft was analyzed using H&E staining. The grade of cellularity and the metaplasia were evaluated on an enlarged image. Black arrows indicate round, white arrows indicate oblong, red arrows indicate spindle, and yellow arrows indicate linear shapes. Magnification ×100 and ×200, scale bar: 200 μm. C The cellularity and metaplasia grade was calculated on 4 consecutive slides 4 and 8 weeks after ACLR. D Picrosirius red staining of rat tendon graft was performed to observe the crimp pattern (black arrow) with a polarized light microscope. Magnification ×200, scale bar: 200 μm. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ns: not significant. Statistical analysis of the data was performed using a 2-way analysis of variance. Data are shown as mean ± standard error of the meanCC BY-NC-ND · PubMed Central
Fig. 6 Matrix protein contents and gene expression in a rat after ACLR. A Immunohistochemical staining of rat tendon graft was performed for types I and III collagen. Magnification ×200, scale bar: 200 μm. B Immunofluorescence staining of rat tendon graft for Ki-67 (green) and type I collagen (red). Ki-67 or type I collagen-positive cells were counted on 4 consecutive slides at 4 and 8 weeks (n = 4). Magnification ×1000, scale bar: 20 μm. C The mRNA expression levels of collagens (type I and III collagen) and ligament-related markers (COMP and tenescin C) were analyzed by RT-qPCR (n = 3). D Immunofluorescence staining of rat tendon grafts for Ku-80 (red) and type I collagen (green). Magnification ×1000, scale bar: 20 μm. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ns: not significant. Statistical analysis of the data was performed using a 1-way analysis of variance. Data are shown as mean ± standard error of the mean
Fig. 6 Matrix protein contents and gene expression in a rat after ACLR. A Immunohistochemical staining of rat tendon graft was performed for types I and III collagen. Magnification ×200, scale bar: 200 μm. B Immunofluorescence staining of rat tendon graft for Ki-67 (green) and type I collagen (red). Ki-67 or type I collagen-positive cells were counted on 4 consecutive slides at 4 and 8 weeks (n = 4). Magnification ×1000, scale bar: 20 μm. C The mRNA expression levels of collagens (type I and III collagen) and ligament-related markers (COMP and tenescin C) were analyzed by RT-qPCR (n = 3). D Immunofluorescence staining of rat tendon grafts for Ku-80 (red) and type I collagen (green). Magnification ×1000, scale bar: 20 μm. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ns: not significant. Statistical analysis of the data was performed using a 1-way analysis of variance. Data are shown as mean ± standard error of the meanCC BY-NC-ND · PubMed Central
Fig. 7 Mechanical properties. A Soft tissues surrounding the tendon graft were removed (yellow arrow: Achilles tendon graft). B Harvested tissue was fixed with Kirschner wire and bone cement. Failure load (C) and stiffness (D) of tendon graft were measured 8 weeks after ACLR. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ns: not significant. Statistical analysis of the data was performed using a 1-way analysis of variance. Data are shown as mean ± standard error of the mean
Fig. 7 Mechanical properties. A Soft tissues surrounding the tendon graft were removed (yellow arrow: Achilles tendon graft). B Harvested tissue was fixed with Kirschner wire and bone cement. Failure load (C) and stiffness (D) of tendon graft were measured 8 weeks after ACLR. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ns: not significant. Statistical analysis of the data was performed using a 1-way analysis of variance. Data are shown as mean ± standard error of the meanCC BY-NC-ND · PubMed Central
Fig. 8 Micro-CT analysis. A New bone volume of the femoral and tibial tunnels was measured, and B represented with computed tomography images at 8 weeks after ACLR. C Bone volume (BV)/total volume (TV) ratio of femoral and tibial tunnels was calculated 8 weeks after ACLR. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ns: not significant. Statistical analysis of the data was performed using a 1-way analysis of variance. Data are shown as mean ± standard error of the mean
Fig. 8 Micro-CT analysis. A New bone volume of the femoral and tibial tunnels was measured, and B represented with computed tomography images at 8 weeks after ACLR. C Bone volume (BV)/total volume (TV) ratio of femoral and tibial tunnels was calculated 8 weeks after ACLR. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ns: not significant. Statistical analysis of the data was performed using a 1-way analysis of variance. Data are shown as mean ± standard error of the meanCC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

14 Valid · 1 Not valid · 15 Not checked · 76 Own results and interpretations

65 more claims · 5 with their cited sources checked

Create a free account to see all 106 claims and to verify the 5 references still open.

See all claims — free account
  • Probably not a substantial claim. 17
  • It may state two separate claims as one. 21
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Show all 67 references

Research works printed but not linked: 1

  1. Scheffler S, Dustmann M, Gangey I, Schulz T, Unterhauser F, Weiler A. The biological healing and restoration of the mechanical properties of free soft-tissue allografts lag behind autologous ACL reconstruction in the sheep model. Trans Orthop Res. 2005;51:0236.

Cited by

See all 3

Metadata

Authors
Park, J., Soh, H., Jang, Y.-K., Lee, Y. S., Lee, M.-K., Kim, H., Kim, T.-H., Alkhelaifi, K., Kim, T.-J., & Lee, J. K.
Affiliations
  • Hanyang University (KR)
  • Pusan National University (KR)
  • Hanyang University Hospital for Rheumatic Disease (KR)
  • Qatar Orthopaedic and Sports Medicine Hospital (QA)
  • Hanyang University Seoul Hospital (KR)
Corresponding author
  • Lee, Myung-Kyu
  • Kim, Tae-Hwan
  • Kim, Tae-Jin
  • Lee, Jin Kyu
Venue
Stem Cell Research & Therapy
Published
2025-11-14
Volume
16
Issue
1
Pages
638-638
ISSN
1757-6512 (ISSN-L)
OpenAlex
W4416224747
Cited by
3
References
67
Citations by year
2026: 3
FWCI
2.99
Type
journal article
Language
en
Open access
Licence
Locations
  • Stem Cell Research & Therapy (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Research Foundation of Korea (2021R1A6A1A03038899)
  • Korean Fund for Regenerative Medicine (RS-2023-00215515)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Tendon Structure and Treatment
  • Health Sciences › Medicine › Surgery › Knee injuries and reconstruction techniques
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
anterior cruciate ligament reconstruction, biological scaffolds, graft maturation, ligamentization, type I collagen, graft mechanical properties, tissue engineering, rat model
MeSH terms
Anterior Cruciate Ligament Injuries, Animals, Female, Humans, Male, Tendons, Transplantation, Autologous, Anterior Cruciate Ligament, Rats, Sprague-Dawley, Tissue Engineering, Rats, Tissue Scaffolds, Anterior Cruciate Ligament Reconstruction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A new biological enhancement therapy for anterior cruciate ligament reconstruction: the preclinical proof of anterior cruciate ligament reconstruction with tendon graft reseeded with autologous anterior cruciate ligament-derived cells. https://app.cochat.ai/papers/10.1186/s13287-025-04760-1
The paper
Park, J., Soh, H., Jang, Y.-K., Lee, Y. S., Lee, M.-K., Kim, H., Kim, T.-H., Alkhelaifi, K., Kim, T.-J., & Lee, J. K. (2025). A new biological enhancement therapy for anterior cruciate ligament reconstruction: the preclinical proof of anterior cruciate ligament reconstruction with tendon graft reseeded with autologous anterior cruciate ligament-derived cells. Stem Cell Research & Therapy. https://doi.org/10.1186/s13287-025-04760-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.